Eliminate hepatitis 2017: map of countries turning commitment into action to tackle hepatitis

Eliminate hepatitis: WHO

Geneva, 27 July 2017 – New WHO data from 28 countries - representing approximately 70% of the global hepatitis burden - indicate that efforts to eliminate hepatitis are gaining momentum. Published to coincide with World Hepatitis Day, the data reveal that nearly all 28 countries have established high-level national hepatitis elimination committees (with plans and targets in place) and more than half have allocated dedicated funding for hepatitis responses.

Dispensing generic medicines in a public sector hospital, the Philippines

WHO endorses direct-acting antivirals for treatment of hepatitis C

25 July 2017 – Ahead of World Hepatitis Day 2017, the World Health Organization (WHO) strongly encourages countries to continue scaling up access to direct-acting antivirals (DAAs) for the treatment of hepatitis C infection. “The revolution in hepatitis C treatment with DAAs has, for the first time, provided an opportunity for widespread scale-up of curative treatment," said Dr Gottfried Hirnschall, Director of WHO’s Department of HIV and Global Hepatitis Programme.

WHO/Yvan Hutin
World Hepatitis Day 2017 - Posters: Eliminate hepatitis

World Hepatitis Day 2017: Eliminate hepatitis

The World Hepatitis Day on 28 July 2017 is an opportunity to add momentum to all efforts to implement the WHO's first global health sector strategy on viral hepatitis for 2016-2021 and help Member States achieve the final goal - to eliminate hepatitis.


WHO prequalifies first generic hepatitis C medicine and first HIV self-test

21 July 2017 – WHO today prequalified the first generic version of sofosbuvir, a critical medicine for the treatment of hepatitis C. The development could expand access to treatment by increasing the number of quality-assured generic medicines on the market. “Direct acting antiviral medicines such as sofosbuvir are highly effective for treating and curing chronic hepatitis C infection. But, at best, 1 out of 10 people in need had access to these medicines in 2015,” said Dr Gottfried Hirnschall, WHO’s Director of the Global Hepatitis Programme.

Health centre in Egypt

Egypt develops national screening strategy for hepatitis C with WHO support

June 2017 - Egypt aims to treat 1 million people living with HCV every year. Since announcing the strategy (from October 2014 to May 2017), the country has treated more than 1 050 000 patients with chronic hepatitis C infection through the government programme. HCV is one of the main public health challenges affecting Egyptians, with a national prevalence of 4.4% among people aged 1–59 years.

WHO Egypt

fact buffet

Global burden

325 millionEstimated 325 million people were living with chronic hepatitis infections (HBV or HCV) worldwide in 2015.

For more: fact sheet on hepatitis B

Silent killer

1.34 millionGlobally, 1.34 million people died of viral in 2015.

For more: global strategy on viral hepatitis

Effective treatment

>95% Over 95% of people with hepatitis C can be completely cured within 2-3 months.

For more: fact sheet on hepatitis C

World Hepatitis Day 2017

World Hepatitis Summit

World Hepatitis Summit 2017

Date: 1-3 November 2017 Place: São Paulo, Brazil

Global strategy

Global health sector strategy on viral hepatitis 2016-2021

Global health sector strategy on viral hepatitis 2016-2021


Stay connected

Global Hepatitis Programme